First Trust Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.87M Buy
51,365
+18,215
+55% +$814K ﹤0.01% 1946
2025
Q4
$1.54M Buy
33,150
+26,219
+378% +$1.17M ﹤0.01% 1993
2025
Q3
$289K Sell
6,931
-72
-1% -$2.3K ﹤0.01% 2419
2025
Q2
$201K Sell
7,003
-30,755
-81% -$950K ﹤0.01% 2525
2025
Q1
$1.27M Sell
37,758
-158,063
-81% -$5.9M ﹤0.01% 1966
2024
Q4
$10M Sell
195,821
-14,570
-7% -$815K 0.01% 1058
2024
Q3
$10.8M Buy
210,391
+13,430
+7% +$693K 0.01% 1020
2024
Q2
$8.82M Buy
196,961
+95,224
+94% +$4.4M 0.01% 1060
2024
Q1
$4.76M Buy
101,737
+28,280
+38% +$1.11M ﹤0.01% 1313
2023
Q4
$2.61M Buy
+73,457
New +$2.25M ﹤0.01% 1604

Other funds holding CRNX